Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed ...

It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...

Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award‑winning leader in drone ...

The Philippine stock market ended the month slightly below the 6,000-point mark amid global sell-off. The benchmark ...

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES REGINA, SK / ACCESS Newswire / February 27, 2025 / ROK Resources Inc. ("ROK" or the "Company") (TSXV:ROK)(OTCQB:ROKR ...

IonQ (NYSE:IONQ) was a major beneficiary of the quantum computing hype toward the end of last year, with its shares soaring over 620% in just ...

IonQ, the US-based startup specializing in laser-based quantum computing systems, has signed a deal that should see it ...

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week. Here's the list and some potential catalysts.

AI-driven transformation in telecom is well underway, with network operators pursuing varied AI strategies to improve both ...